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SIGNIFICANCE

Kalman, Morissette and George (2005), Am. J. Addict., 14: 106-123

Arguments for Not Providing Tobacco Treatment….
“these patients don’t want to quit”
• 80% of participants in a methadone maintenance program and 75% of participants
in an alcohol abuse program endorsed a desire to quit (Richter KP et al., 2001; Ellingstad TP et al, 1999)
• In a review of 9 studies of motivation to quit smoking among individuals with
psychiatric disorders at least 50% are contemplating cessation (Siru, Hulse & Tait, 2009).

“these patients will relapse (to other substances)
if they try to quit”
• Smoking cessation efforts can ENHANCE rather than compromise
long term sobriety (Prochaska JJ et al, 2004).

“these patients are unable to quit”
• Meta-analysis (n = 19 studies) of smoking cessation among individuals in
addiction treatment and recovery found increased cessation at end of 12 weeks
treatment (BUT NO SIGNIFICANT EFFECT AT 6 MONTHS!) (Prochaska JJ et al, 2004).
• Recent study found end-of-treatment smoking cessation rates of 20% among
individuals with psychiatric disorders accessing outpatient tobacco treatment
program-Longer duration of treatment significantly predicted successful
cessation.

Program Description
• The Tobacco Dependence Clinic (TDC) is a program that
provides behavioural counselling and up to 6-7months of nocost pharmacotherapy for clients through VCH Addiction
Services
• Program is run with a team of nurses, counsellors, respiratory
therapists, and a physician.
• Currently in 7 Addictions services located in community
health centres in Vancouver.
Eligibility:
• 19 years or older
• Tobacco dependent
• Have a history of substance use disorder and/or mental illness
• Financially disadvantaged

Treatment Approach

8-week structured group:
Phase 1: engagement in the process – weeks 1-2
Phase 2: planning for change – weeks 3-4
Phase 3: sustaining change – weeks 5-8

Program philosophy: Quitting smoking is a process and not an event

Specific Aims
• To assess program completion and smoking cessation
rates at end-of-treatment
• To examine predictors of successful program
completion and smoking cessation

Sample for Evaluation
678
Intent-to-treat

155

523

Program non-completers

program completers

• Analysis is based on a retrospective chart review of participants in the TDC
program (between Sept 2007 and Dec, 2011) from 7 clinics, in Vancouver, Canada
• Smoking cessation: 7-day point-prevalence of abstinence at end of treatment
(i.e., anytime between 8 weeks to 26 weeks) verified by expired CO levels
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Sample Characteristics (N = 678, 57% male)
Mean

Stand. Dev.

Age of participant (years)

48.0

11.0

Age at smoking initiation (years)

15.1

5.8

Importance of quitting (scale of 0 ‘low’ to 10 ‘high’)

9.0

1.4

Confidence in quitting (scale of 0 ‘low’ to 10 ‘high’)

7.2

2.4

Number of cigarettes smoked per day

20.4

10.3

Fagerstrom Test for Nicotine Dependence

6.0

2.0

20.9

14.2

(scale of 0 ‘low’ to 10 ‘high’)

CO level at baseline (ppm)

Program Completion (n = 523/678)
100

77.1%

Percent %
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Smoking Cessation* Outcomes at end-of-treatment
Quit
Not quit

100

67.3

59.7

80
60

32.7

40.3

40
20
0

Intent to treat (N=678)

Program completers (n = 523)

*Smoking cessation at end-of-treatment (i.e., anytime between 8 weeks to 26 weeks)
verified by expired CO levels

Smoking cessation by SUD and PD among
program completers (n = 523)*
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Smoking Cessation by length of stay in the program
(n = 678)*
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* Statistically significant differences between groups

Multivariate predictorsa of program completion (n = 674)
Predictors

Odds Ratio

95%CI

Gender
Male (referent)
Female

1.0
1.78**

1.19-2.65

Age

1.03**

1.01-1.05

Hosmer-Lemeshow goodness-of-fit: χ2= 1.80 (DF=8), p=.986

a. Employing a two-step model building process in which variables associated with
smoking cessation (at alpha < 1.0) in the unadjusted analyses are included in a
second-step for adjusted analyses. Only variables which were significantly predictive of
smoking cessation in the final adjusted multivariate model are shown.
* = p <.05, ** = p <.001, *** = p <.001

Multivariate predictorsa of smoking cessation among
program completers at end of treatment (n = 494)
Predictors

Odds Ratio

95%CI

History of Psychiatric Disorder
None (referent)
Mood disorder
Anxiety disorder
Psychotic disorder

1.0
.90
.53*
.69

.57-1.42
.29-1.00
.31-1.57

FTND at baseline

.89*

.80-1.00

1.07***

1.04-1.10

Number of Visits to the TDC

Hosmer-Lemeshow goodness-of-fit: χ2= 3.45 (DF=8), p=.903
a.

Employing a two-step model building process in which variables associated with smoking cessation (at alpha < 1.0)
in the unadjusted analyses are included in a second-step for adjusted analyses. Only variables which were
significantly predictive of smoking cessation in the final adjusted multivariate model are shown.

* = p <.05, ** = p <.001, *** = p <.001

Conclusions
• The Tobacco Dependence Clinic provides an innovative model
of tailored tobacco dependence treatment which combines
behavioural counselling with no-cost pharmacotherapy for
individuals with a history of substance use and/or psychiatric
disorders for up to 6 months.
• With intensive tobacco dependence treatment provided within
Mental Health and Addictions services, individuals with a
history of substance use and/or psychiatric disorders are able
to achieve smoking abstinence.

